Iteos and GSK Initiate Galaxies Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic Pd-L1 Selected Non-Small Cell Lung Cancer
愛文思控股和葛蘭素史克啓動星系肺部-301第三階段研究，評估貝羅斯托圖和多斯塔利姆治療未經治療、不可切除的晚期/轉移性Pd-L1選定的非小細胞肺癌。